Loading stock data…
Medpace Holdings (MEDP)
$601.38-4.44 (-0.73%)
Market ClosedLast close Jul 24
Medpace Holdings, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Medpace Holdings, Inc. in the Healthcare sector is trading at $601.38 with a market capitalization of $13.1B. Wall Street consensus targets $570.67 (12 analysts), implying a -5.1% move over the next 12 months. The stock is currently 11% below its 52-week high of $677.90, remaining 16.4% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 95/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply -5.1% downside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $706.60M↓ | $708.45M↑ | $659.90M↑ | $603.31M↑ | $558.57M |
| Gross Profit | $196.33M↓ | $205.32M↑ | $196.94M↑ | $180.01M↑ | $178.35M |
| Operating Income | $141.50M↓ | $153.27M↑ | $141.81M↑ | $126.33M↑ | $113.52M |
| Net Income | $123.87M↓ | $135.13M↑ | $111.14M↑ | $90.26M↓ | $114.59M |
Peer Comparison
JNJUNHPFE
Fundamentals
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development proc...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$13.06B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
76.95%
Volume
Today's trading volume
485,099
Recent News
Why Medpace Holdings (MEDP) Is Up 11.8% After Raising 2026 Guidance And Expanding Backlog
In July 2026, Medpace Holdings reported second-quarter results showing year-over-year increases in revenue and net income, and subsequently raised its 2026 guidance to forecast total revenue of US$2.81 billion–US$2.89 billion and net income of US$494 million–US$514 million, alongside updated earnings per diluted share of US$17.25–US$17.95. The company also reported record net new business awards, a backlog of about US$3.00 billion, and completed a sizeable share repurchase program totaling...
Medpace Holdings, Inc. (MEDP) Hit a 52 Week High, Can the Run Continue?
Medpace (MEDP) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
2 Momentum Stocks with Exciting Potential and 1 We Question
Exciting developments are taking place for the stocks in this article. They’ve all surged ahead of the broader market over the last month as catalysts such as new products and positive media coverage have propelled their returns.
Medpace Holdings Inc (MEDP) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and Record ...
Medpace Holdings Inc (MEDP) reports a robust 17.2% revenue increase and a 34.5% rise in net income, driven by a strong business environment and strategic shifts in program focus.
Medpace Notches A Big Bookings Beat, And Reverses Its First-Quarter Malaise
Medpace stock surged by double digits Thursday, helped by a big bookings beat, rebounding from a poor start to the year.